XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/02/2026
Back to search
Official data from USPTO
NEURIZON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
07/02/2026
Trademark type
Word
Nice classes
42
Filing date
10/28/2024
Registration date
12/23/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/23/2025
Last transaction
07/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
DAVIS, ALEXIS A
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Neurizon Therapeutics Limited
PharmAust Limited
Representatives
Katherine Koenig Koenig IP Works, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development services; development of pharmaceutical preparations and medicines; research and development services of new pharmaceutical products; consultancy relating to pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical testing; pharmaceutical product evaluation; providing information about the results of clinical trials for pharmaceuticals; biologicalclinical neurological and medical research; consultancy relating to research and development in the field of neurological therapeutics; conducting scientific research in the nature of conducting clinical trials for others; providing information and data for research purposes relating to medical and veterinary research and development; providing information relating to medical research in the field of veterinary pharmacovigilance; veterinary research; veterinary research laboratory services; scientific research for medical purposes in the field of neurological diseases; pharmaceutical drug development services
Publications
History of USPTO decisions and trademark events.
31 publications found
XXCR
GENERIC MADRID TRANSACTION CREATED
07/02/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/07/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/20/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/20/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/23/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/23/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/23/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/04/2025
PUBO
PUBLISHED FOR OPPOSITION
11/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/29/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/26/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/07/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
07/01/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/01/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
07/01/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/01/2025
RFNT
REFUSAL PROCESSED BY IB
06/27/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/13/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/13/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/13/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/10/2025
RFRR
REFUSAL PROCESSED BY MPU
06/10/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/08/2025
CNRT
NON-FINAL ACTION WRITTEN
04/07/2025
DOCK
ASSIGNED TO EXAMINER
03/26/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/09/2025
MAFR
APPLICATION FILING RECEIPT MAILED
11/22/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/22/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/21/2024
Continuous trademark protection
Get notified about every new filing that threatens NEURIZON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.